GLIMISAVE MV 2.3 TAB
Original price was: ₹143.32.₹128.99Current price is: ₹128.99.
Glimisave Mv 2.3 Tablet is a medicine that contains Glimepiride, Metformin, and Voglibose, used to control blood sugar levels in individuals with type 2 diabetes.
Out of stock
Description
Glimisave MV 2. 3 Tablet is a combination medication that contains three active ingredients: Glimepiride, Metformin, and Voglibose. Glimepiride belongs to the class of drugs known as sulfonylureas, which helps control blood sugar levels by stimulating the release of insulin from the pancreas. Metformin is a biguanide drug that lowers glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that delays the digestion and absorption of carbohydrates in the intestine, thereby reducing postprandial hyperglycemia. Glimisave MV 2. 3 Tablet is prescribed to individuals with type 2 diabetes mellitus to help manage their blood glucose levels. It assists in lowering blood sugar by increasing insulin secretion, reducing insulin resistance, and slowing down carbohydrate absorption. The combination of these three drugs provides an effective and comprehensive approach to diabetes management.
Additional information
| Marketed by | |
|---|---|
| Composition | |
| Dosage form | TABLET |
| Prescription | REQUIRED |
| Therapeutic use | ANTI DIABETICS |
Note: The actual product packaging may vary slightly from the images shown on our website. Due to manufacturer updates, there may be variations in packaging design. We strive to provide accurate representations of all products.
